{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:08:52Z","timestamp":1790770132553,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.humpath.2007.05.009","type":"journal-article","created":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T17:16:46Z","timestamp":1190999806000},"page":"1849-1857","source":"Crossref","is-referenced-by-count":26,"title":["Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma"],"prefix":"10.1016","volume":"38","author":[{"given":"C.S.","family":"Chim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Loong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2007.05.009_bib1","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2007.05.009_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<295::AID-AJH5>3.0.CO;2-N","article-title":"Mantle cell lymphoma in Chinese: clinicopathological features and treatment outcome","volume":"59","author":"Chim","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2007.05.009_bib3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood-2002-07-2009","article-title":"Cell cycle deregulation in B-cell lymphomas","volume":"101","author":"Sanchez-Beato","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.05.009_bib4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMra021902","article-title":"Rules for making human tumor cells","volume":"347","author":"Hann","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2007.05.009_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/35106065","article-title":"To cycle or not to cycle: a critical decision in cancer","volume":"1","author":"Malumbres","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2007.05.009_bib6","first-page":"3689","article-title":"The Pezcoller lecture: cancer cell cycles revisited","volume":"60","author":"Sherr","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2007.05.009_bib7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nrc950","article-title":"The retinoblastoma tumor suppressor in development and cancer","volume":"2","author":"Classon","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2007.05.009_bib8","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/sj.onc.1202998","article-title":"The INK4 family of cell cycle inhibitors in cancer","volume":"18","author":"Roussel","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2007.05.009_bib9","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1101\/gad.851100","article-title":"Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors","volume":"14","author":"Jeffey","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.humpath.2007.05.009_bib10","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2007.05.009_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hon.694","article-title":"Hypermethylation of gene promoters in hematologic neoplasia","volume":"20","author":"Chim","year":"2002","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.humpath.2007.05.009_bib12","series-title":"Tumor suppressor genes, the cell cycle and cancer","first-page":"43","article-title":"The retinoblastoma gene and gene product","author":"Weinberg","year":"1992"},{"key":"10.1016\/j.humpath.2007.05.009_bib13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.leu.2401043","article-title":"Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells","volume":"12","author":"Drexler","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2007.05.009_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/MCB.20.1.372-378.2000","article-title":"INK4d-deficient mice are fertile despite testicular atrophy","volume":"20","author":"Zindy","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2007.05.009_bib15","series-title":"Molecular cloning: a laboratory manual","first-page":"280","author":"Maniatis","year":"1982"},{"key":"10.1016\/j.humpath.2007.05.009_bib16","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1200\/JCO.2001.19.7.2033","article-title":"Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance","volume":"19","author":"Chim","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2007.05.009_bib17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.leu.2403676","article-title":"Absence of ATM hypermethylation in mantle cell and follicular lymphoma","volume":"19","author":"Chim","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2007.05.009_bib18","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands","volume":"93","author":"Herman","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2007.05.009_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/jhep.2002.34852","article-title":"Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma","volume":"36","author":"Roncalli","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2007.05.009_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.36.10.793","article-title":"A PCR test for the detection of hypermethylated alleles at the retinoblastoma locus","volume":"36","author":"Zeschnigk","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/j.humpath.2007.05.009_bib21","first-page":"339","article-title":"Wild-type and mutant retinoblastoma protein in paraffin sections","volume":"9","author":"Geradts","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2007.05.009_bib22","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1054\/bjoc.2000.1435","article-title":"Cell cycle regulators p27 and pRb in lymphomas\u2014correlation with histology and proliferative activity","volume":"83","author":"Kiviniemi","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2007.05.009_bib23","first-page":"1591","article-title":"Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1\/CCND1) mRNA levels and proliferative activity","volume":"148","author":"Jares","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2007.05.009_bib24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ajcp\/105.5.538","article-title":"Immunohistochemical detection of p53, BCL-2, and retinoblastoma proteins in follicular lymphoma","volume":"105","author":"Nguyen","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2007.05.009_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/gcc.20277","article-title":"Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma","volume":"45","author":"Hutter","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2007.05.009_bib26","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.05.009_bib27","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/sj.leu.2401090","article-title":"Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb","volume":"12","author":"Gronbaek","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2007.05.009_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1309\/LCGNV77J464LNFD6","article-title":"Differential DNA methylation of gene promoters in small B-cell lymphomas","volume":"124","author":"Guo","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2007.05.009_bib29","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1101\/gad.8.24.2939","article-title":"Growth suppression by p18, a p16INK4\/MTS1- and p14INK4B\/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function","volume":"8","author":"Guan","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.humpath.2007.05.009_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2141.1997.4333243.x","article-title":"Analysis of p18INK4C in adult T-cell leukemia and non-Hodgkin's lymphoma","volume":"99","author":"Hatta","year":"1997","journal-title":"Br J Haematol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817707002614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817707002614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T22:17:03Z","timestamp":1587939423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817707002614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0046817707002614"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2007.05.009","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}